Follow
Julie Rayes
Title
Cited by
Cited by
Year
Functional significance of the platelet immune receptors GPVI and CLEC-2
J Rayes, SP Watson, B Nieswandt
The Journal of clinical investigation 129 (1), 12-23, 2019
2642019
Platelets in sepsis: an update on experimental models and clinical data
A Assinger, WC Schrottmaier, M Salzmann, J Rayes
Frontiers in immunology 10, 459996, 2019
2092019
Podoplanin: an emerging cancer biomarker and therapeutic target
H Krishnan, J Rayes, T Miyashita, G Ishii, EP Retzbach, SA Sheehan, ...
Cancer science 109 (5), 1292-1299, 2018
1562018
Complement factor H inhibits CD47-mediated resolution of inflammation
B Calippe, S Augustin, F Beguier, H Charles-Messance, L Poupel, ...
Immunity 46 (2), 261-272, 2017
1382017
Heme: modulator of plasma systems in hemolytic diseases
LT Roumenina, J Rayes, S Lacroix-Desmazes, JD Dimitrov
Trends in molecular medicine 22 (3), 200-213, 2016
1352016
The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
J Rayes, S Lax, S Wichaiyo, SK Watson, Y Di, S Lombard, B Grygielska, ...
Nature communications 8 (1), 2239, 2017
1342017
The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation
J Rayes, JH Bourne, A Brill, SP Watson
Research and practice in thrombosis and haemostasis 4 (1), 23-35, 2020
1262020
Endothelial cells: source, barrier, and target of defensive mediators
LT Roumenina, J Rayes, M Frimat, V Fremeaux‐Bacchi
Immunological reviews 274 (1), 307-329, 2016
1132016
The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status
J Rayes, LT Roumenina, JD Dimitrov, Y Repessé, M Ing, O Christophe, ...
Blood, The Journal of the American Society of Hematology 123 (1), 121-125, 2014
832014
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS‐13
J Rayes, A Hommais, P Legendre, H Tout, A Veyradier, B Obert, AS Ribba, ...
Journal of Thrombosis and Haemostasis 5 (2), 321-328, 2007
802007
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B
J Rayes, MJ Hollestelle, P Legendre, I Marx, PG de Groot, OD Christophe, ...
Blood, The Journal of the American Society of Hematology 115 (23), 4870-4877, 2010
772010
Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse
S Lax, J Rayes, S Wichaiyo, EJ Haining, K Lowe, B Grygielska, R Laloo, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 313 (6 …, 2017
712017
Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2
JH Bourne, M Colicchia, Y Di, E Martin, A Slater, LT Roumenina, ...
Haematologica 106 (2), 626, 2021
632021
Venous thromboembolism in brain tumors: risk factors, molecular mechanisms, and clinical challenges
J Riedl, C Ay
Seminars in thrombosis and hemostasis 45 (04), 334-341, 2019
582019
The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent
J Rayes, S Jadoui, S Lax, A Gros, S Wichaiyo, V Ollivier, CV Denis, ...
Haematologica 103 (6), e256, 2018
572018
In vivo analysis of the role of O-glycosylations of von Willebrand factor
I Badirou, M Kurdi, P Legendre, J Rayes, M Bryckaert, C Casari, ...
PLoS One 7 (5), e37508, 2012
442012
Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)
A Hommais, J Rayes, A Houllier, B Obert, P Legendre, A Veyradier, ...
Thrombosis and haemostasis 98 (09), 593-599, 2007
402007
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein
P Legendre, AM Navarrete, J Rayes, C Casari, P Boisseau, C Ternisien, ...
Blood, The Journal of the American Society of Hematology 121 (11), 2135-2143, 2013
392013
Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice
S Wichaiyo, S Lax, SJ Montague, Z Li, B Grygielska, JA Pike, EJ Haining, ...
Haematologica 104 (8), 1648, 2019
382019
Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies
AO Khan, A Rodriguez-Romera, JS Reyat, AA Olijnik, M Colombo, ...
Cancer discovery 13 (2), 364-385, 2023
372023
The system can't perform the operation now. Try again later.
Articles 1–20